Clinical Trials Browser

Phase 3 × Peripheral Nervous System Diseases × Bortezomib × Clear all

NCT02362165 2016-04-20

CyBorD vs. PAD in the Treatment of Newly Diagnosed Multiple Myeloma

Phase 3 Unknown

Multiple Myeloma, Peripheral Nervous System Diseases